Article Text
PDFAfterword
Afterword: returning to philosophical foundations in research ethics
Abstract
This is an afterword to the JME symposium on the benefit/risk ratio challenge in clinical research, and the case of HIV cure. It notes implications of the symposium for research ethics in general.
- HIV Infection and AIDS
- Research Ethics
- Ethics
Statistics from Altmetric.com
Footnotes
Funding This work was funded by NIAID grants 1 R01 AI114617-01A1 and 1 R56 AI114617-01, both titled ‘HIV cure studies: risk, risk perception, and ethics’. The study sponsor had no role in the study design; in the collection, analysis and interpretation of the data; in the writing of the report and in the decision to submit the paper for publication.
Competing interests None declared.
Provenance and peer review Not commissioned; internally peer reviewed.
Linked Articles
- Benefits to nonparticipants
Read the full text or download the PDF:
Other content recommended for you
- How to keep high-risk studies ethical: classifying candidate solutions
- Ethics of treatment interruption trials in HIV cure research: addressing the conundrum of risk/benefit assessment
- Ethics of vaccine refusal
- Human infection challenge studies in endemic settings and/or low-income and middle-income countries: key points of ethical consensus and controversy
- The Gettier Problem in informed consent
- Beyond informed consent: the therapeutic misconception and trust
- The benefit/risk ratio challenge in clinical research, and the case of HIV cure: an introduction
- Nudge me, help my baby: on other-regarding nudges
- The morality of risks in research: reflections on Kumar
- Streamlining the Clinical Research Enterprise